Full Text
Cost Effectiveness of Intensive Lowering of Ldl Cholesterol with Pcsk9 Inhibitors as an Adjunct to High-Intensity Statin Therapy for Prevention of Major Vascular Events

Abstract

Authors

H Lee J Watkins D Danielson

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×